Published in Medicine (Baltimore) on May 01, 2016
Associations between prescribed Chinese herbal medicine and risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide population-based cohort study. BMJ Open (2017) 0.77
Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity. PLoS One (2016) 0.75
Link between plasminogen activator inhibitor-1 and cardiovascular risk in chronic hepatitis C after viral clearance. Sci Rep (2017) 0.75
Prevalence of conventional risk factors in patients with coronary heart disease. JAMA (2003) 6.84
Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med (1975) 5.49
Menopause and risk factors for coronary heart disease. N Engl J Med (1989) 3.84
The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology (2013) 3.14
Community-wide cardiovascular disease prevention programs and health outcomes in a rural county, 1970-2010. JAMA (2015) 2.26
Fatty liver: imaging patterns and pitfalls. Radiographics (2006) 2.21
Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol Metab (2009) 2.05
Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J Hepatol (2008) 1.82
Sex hormones and coronary disease: a review of the clinical studies. Steroids (1990) 1.25
Hepatitis B virus infection and fatty liver in the general population. J Hepatol (2011) 1.25
Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors. J Med Virol (2001) 1.22
Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment Pharmacol Ther (2013) 1.21
Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management. J Hepatol (2014) 1.18
Sex differences in the metabolic syndrome: implications for cardiovascular health in women. Clin Chem (2013) 1.16
Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol (2008) 1.16
Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology (1994) 1.16
Sex-specific differences in lipid and glucose metabolism. Front Endocrinol (Lausanne) (2015) 1.08
Elevated lipogenesis and diminished cholesterol synthesis in patients with hepatitis C viral infection compared to healthy humans. Hepatology (2013) 1.01
Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys. J Viral Hepat (2010) 1.01
Natural history and management of hepatitis C: does sex play a role? J Infect Dis (2014) 1.00
Sex differences in infectious diseases-common but neglected. J Infect Dis (2014) 1.00
Treatment of chronic hepatitis C in southern Taiwan. Intervirology (2006) 0.99
Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies. Gastroenterology (2015) 0.99
Hepatitis C infection and clearance: impact on atherosclerosis and cardiometabolic risk factors. Gut (2010) 0.95
Immigration and viral hepatitis. J Hepatol (2015) 0.93
Metabolic alterations and hepatitis C: From bench to bedside. World J Gastroenterol (2016) 0.91
Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearance. PLoS One (2014) 0.89
Impact of hepatitis B virus infection on metabolic profiles and modifying factors. J Viral Hepat (2011) 0.88
Lower prevalence of hypercholesterolemia and hyperglyceridemia found in subjects with seropositivity for both hepatitis B and C strains independently. J Gastroenterol Hepatol (2010) 0.88
Chronic hepatitis B infection and risk of atherosclerosis-related mortality: A 17-year follow-up study based on 22,472 residents in Taiwan. Atherosclerosis (2010) 0.88
Demographic characteristics and medical aspects of menopausal women in Taiwan. J Formos Med Assoc (1997) 0.84
Injection with nondisposable needles as an important route for transmission of acute community-acquired hepatitis C virus infection in Taiwan. J Med Virol (1995) 0.84
Association between obesity, hypertriglyceridemia and low hepatitis B viral load. Int J Obes (Lond) (2012) 0.84
Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders. J Gastroenterol Hepatol (2015) 0.83
Serum adiponectin levels are associated with hepatitis B viral load in overweight to obese hepatitis B virus carriers. Obesity (Silver Spring) (2013) 0.83
HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer. PLoS One (2011) 0.82
Chronic HCV infection increases cardiac left ventricular mass index in normotensive patients. J Hepatol (2014) 0.81
"Immune activation, aging and gender" and progression of liver disease. Acta Biomed (2011) 0.81
Anti-hepatitis C virus seropositivity is not associated with metabolic syndrome irrespective of age, gender and fibrosis. Ann Hepatol (2015) 0.80
Impact of triglycerides on lipid and lipoprotein biology in women. Gend Med (2010) 0.80
Postmenopausal hormone replacement therapy and cardiovascular risk reduction. A review. Drugs (1994) 0.79
Cardiovascular Disease-Risk Markers in HIV Patients. J AIDS Clin Res (2014) 0.78
High rate of hepatitis C virus infection in an isolated community: persistent hyperendemicity or period-related phenomena? J Med Virol (1997) 0.77
Clinical events after cessation of lamivudine therapy in patients recovered from hepatitis B flare with hepatic decompensation. Clin Gastroenterol Hepatol (2014) 0.77
Obesity, Metabolic Health, and History of Cytomegalovirus Infection in the General Population. J Clin Endocrinol Metab (2016) 0.76
Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapy. Hepatology (2011) 2.93
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology (2002) 2.83
Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination. Gastroenterology (2012) 1.97
Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology (2004) 1.85
Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology (2010) 1.77
No benefit to continue lamivudine therapy after emergence of YMDD mutations. Antivir Ther (2004) 1.62
Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance. Gastroenterology (2006) 1.62
Determinants for sustained HBeAg response to lamivudine therapy. Hepatology (2003) 1.38
Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: a randomized phase II study. Hepatology (2012) 1.31
Health-promoting lifestyles of university students in mainland China. BMC Public Health (2009) 1.13
Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma. PLoS One (2012) 1.10
Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. World J Gastroenterol (2005) 1.04
Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res (2012) 1.03
The indispensable role of CCR5 for in vivo suppressor function of tumor-derived CD103+ effector/memory regulatory T cells. J Immunol (2012) 1.03
Precore stop mutant in HBeAg-positive patients with chronic hepatitis B: clinical characteristics and correlation with the course of HBeAg-to-anti-HBe seroconversion. J Clin Microbiol (2002) 1.02
The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutant. Antivir Ther (2008) 1.02
Irregular breakfast eating and health status among adolescents in Taiwan. BMC Public Health (2006) 1.01
Esophageal perforation caused by fish vertebra ingestion in a seven-month-old infant demanded surgical intervention: A case report. World J Gastroenterol (2006) 1.00
Clinical significance of and outcomes for Bacteroides fragilis bacteremia. J Microbiol Immunol Infect (2009) 0.97
Network analysis and proteomic identification of vimentin as a key regulator associated with invasion and metastasis in human hepatocellular carcinoma cells. J Proteomics (2012) 0.95
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study. Hepatol Int (2007) 0.94
Alcohol, betel-nut and cigarette consumption are negatively associated with health promoting behaviors in Taiwan: a cross-sectional study. BMC Public Health (2013) 0.93
Thyroid hormone promotes cell invasion through activation of furin expression in human hepatoma cell lines. Endocrinology (2008) 0.93
Overexpression of cyclin-dependent kinase-associated protein phosphatase enhances cell proliferation in renal cancer cells. Urol Oncol (2011) 0.92
Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis. BMC Genomics (2008) 0.91
Thyroid hormone receptors suppress pituitary tumor transforming gene 1 activity in hepatoma. Cancer Res (2008) 0.91
Effects of cyclosporin A and a rapamycin derivative (SAR943) on chronic allergic inflammation in sensitized rats. Immunology (2003) 0.89
A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma. Int J Cancer (2013) 0.88
Furin overexpression suppresses tumor growth and predicts a better postoperative disease-free survival in hepatocellular carcinoma. PLoS One (2012) 0.88
Expression of the HCRP1 mRNA in HCC as an independent predictor of disease-free survival after surgical resection. Hepatol Res (2009) 0.88
Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B. J Hepatol (2005) 0.88
Adenovirus type 5 E1A sensitizes hepatocellular carcinoma cells to gemcitabine. Cancer Res (2003) 0.88
Effector/memory but not naive regulatory T cells are responsible for the loss of concomitant tumor immunity. J Immunol (2009) 0.88
Interaction of hepatitis C virus F protein with prefoldin 2 perturbs tubulin cytoskeleton organization. Biochem Biophys Res Commun (2006) 0.87
Identification of a two-layer regulatory network of proliferation-related microRNAs in hepatoma cells. Nucleic Acids Res (2012) 0.87
Prevention of Liver Cancer Through the Early Detection of Risk-related Behavior Among Hepatitis B or C Carriers. Cancer Nurs (2015) 0.87
Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy. Antivir Ther (2009) 0.86
GALNT14 SNP as a potential predictor of response to combination chemotherapy using 5-FU, mitoxantrone and cisplatin in advanced HCC. Pharmacogenomics (2011) 0.86
Haploidentical donor T cells fail to facilitate engraftment but lessen the immune response of host T cells in murine fetal transplantation. Br J Haematol (2004) 0.86
Short-term effects of a health promotion course for Taiwanese nursing students. Public Health Nurs (2005) 0.86
Dickkopf 4 positively regulated by the thyroid hormone receptor suppresses cell invasion in human hepatoma cells. Hepatology (2012) 0.85
Inhibition of hepatitis C virus replication by arsenic trioxide. Antimicrob Agents Chemother (2004) 0.85
The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii. J Infect (2011) 0.85
WIF-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions. J Cancer Res Clin Oncol (2008) 0.85
293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infection. J Med Virol (2009) 0.85
Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections. Medicine (Baltimore) (2016) 0.85
Using principal component analysis to develop a single-parameter screening tool for metabolic syndrome. BMC Public Health (2010) 0.84
Hepatic inflammation mediated by hepatitis C virus core protein is ameliorated by blocking complement activation. BMC Med Genomics (2009) 0.84
Identification of a novel actin isoform in hepatocellular carcinoma. Hepatol Res (2006) 0.84
Prenatal tolerance induction: relationship between cell dose, marrow T-cells, chimerism, and tolerance. Cell Transplant (2008) 0.84
Comparison of childhood hepatic malignancies in a hepatitis B hyper-endemic area. World J Gastroenterol (2005) 0.84
Thyroid hormone enhanced human hepatoma cell motility involves brain-specific serine protease 4 activation via ERK signaling. Mol Cancer (2014) 0.83
Acute expression of hepatitis C core protein in adult mouse liver: Mitochondrial stress and apoptosis. Scand J Gastroenterol (2008) 0.83
Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study. Scand J Gastroenterol (2014) 0.83
New enzyme-linked immunosorbent assay for detection of antibodies against hepatitis delta virus using a hepatitis delta antigen derived from a Taiwanese clone and comparison to the Abbott radioimmunoassay. Clin Vaccine Immunol (2012) 0.83
Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders. J Gastroenterol Hepatol (2015) 0.83
The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network. Medicine (Baltimore) (2016) 0.83
Liver transplantation in patients with hepatitis B virus-related hepatocellular carcinoma: the influence of viral characteristics on clinical outcome. Ann Surg Oncol (2013) 0.82
SLC25A13 gene mutations in Taiwanese patients with non-viral hepatocellular carcinoma. Mol Genet Metab (2011) 0.82
HURP expression-assisted risk scores identify prognosis distinguishable subgroups in early stage liver cancer. PLoS One (2011) 0.82
Topological and evolutional relationships between HCV core protein and hepatic lipid vesicles: studies in vitro and in conditionally transgenic mice. World J Gastroenterol (2007) 0.82
Identification of NV-F virus DNA in hepatocellular carcinoma. J Med Virol (2007) 0.82
Identification of hepatitis B virus rtS117F substitution as a compensatory mutation for rtM204I during lamivudine therapy. J Antimicrob Chemother (2011) 0.82
The impact of shift work on nurses' job stress, sleep quality and self-perceived health status. J Nurs Manag (2012) 0.82
Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation. Proteomics (2008) 0.82
Identification of a novel pre-S2 mutation in a subgroup of chronic carriers with spontaneous clearance of hepatitis B virus surface antigen. J Gastroenterol Hepatol (2003) 0.81
One single nucleotide difference alters the differential expression of spliced RNAs between HBV genotypes A and D. Virus Res (2013) 0.81
Thyroid hormone receptor-mediated regulation of the methionine adenosyltransferase 1 gene is associated with cell invasion in hepatoma cell lines. Cell Mol Life Sci (2010) 0.80
Hyperuricemia is an independent risk factor for new onset micro-albuminuria in a middle-aged and elderly population: a prospective cohort study in taiwan. PLoS One (2013) 0.80
Cell cycle perturbation in the hepatocytes of HCV core transgenic mice following common bile duct ligation is associated with enhanced p21 expression. J Med Virol (2009) 0.80
Misperception among rural diabetic residents: a cross-sectional descriptive study. J Adv Nurs (2012) 0.80
Factors associated with numbers of remaining teeth among type 2 diabetes: a cross-sectional study. J Clin Nurs (2013) 0.80
Useful screening tools for preventing foot problems of diabetics in rural areas: a cross-sectional study. BMC Public Health (2013) 0.79
HCV core-induced nonobese hepatic steatosis is associated with hypoadiponectinemia and is ameliorated by adiponectin administration. Obesity (Silver Spring) (2012) 0.79
Overexpression of kappa-actin alters growth properties of hepatoma cells and predicts poor postoperative prognosis. Anticancer Res (2011) 0.79
Hydrodynamics-based transfection of the combination of betacellulin and neurogenic differentiation 1 DNA ameliorates hyperglycemia in mice with streptozotocin-induced diabetes. Diabetes Technol Ther (2011) 0.79
Prevention of graft rejection by donor type II CD8(+) T cells (Tc2 cells) is not sufficient to improve engraftment in fetal transplantation. Fetal Diagn Ther (2004) 0.79
A gene expression restriction network mediated by sense and antisense Alu sequences located on protein-coding messenger RNAs. BMC Genomics (2013) 0.78
Large fragment pre-S deletion and high viral load independently predict hepatitis B relapse after liver transplantation. PLoS One (2012) 0.78
[The relationship between adolescent body size and health promoting behavior and biochemical indicator factors]. Hu Li Za Zhi (2012) 0.78
The impact of hepatitis C infection on ischemic heart disease via ischemic electrocardiogram. Am J Med Sci (2014) 0.78
Reticulon 3 interacts with NS4B of the hepatitis C virus and negatively regulates viral replication by disrupting NS4B self-interaction. Cell Microbiol (2014) 0.78
The relationship between geriatric depression and health-promoting behaviors among community-dwelling seniors. J Nurs Res (2013) 0.78
Development and preliminary testing of a brief screening measure of healthy lifestyle for diabetes patients. Int J Nurs Stud (2012) 0.78
Occult and Overt HBV Co-Infections Independently Predict Postoperative Prognosis in HCV-Associated Hepatocellular Carcinoma. PLoS One (2013) 0.78
Emergence and takeover of precore-stop mutant prior to exacerbation of e antigen-negative chronic hepatitis B after withdrawal of lamivudine therapy. J Med Virol (2006) 0.78
Eliminating hepatitis B virus through neonatal vaccination: can we make it? J Hepatol (2012) 0.78
Inhibition of hepatitis C virus replication by antimonial compounds. Antimicrob Agents Chemother (2005) 0.77
Persistence of allografts in the peritoneal cavity after prenatal transplantation in mice. Transfusion (2007) 0.77
Emergence of mutation clusters in the HCV genome during sequential viral passages in Sip-L expressing cells. J Virol Methods (2005) 0.77